Cited by 353Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Clinical Features of Early-Onset Alzheimer Disease in a Large Kindred With an E280A Presenilin-1 Mutation

Lopera, Francisco·1997·JAMA: The Journal of the American Medical Association

DOI 10.1001/jama.1997.03540340027028

Open this paper in CoChat — free account

Abstract

OBJECTIVES: To characterize clinical features of a very large pedigree with early-onset Alzheimer disease (AD) in which all affected individuals carry the identical glutamic acid-to-alanine mutation at codon 280 in the presenilin-1 gene. DESIGN: Clinical histories were obtained by patient and family interviews and through medical or civil records. Using standard diagnostic criteria, a case series of 128 individuals was identified, of which 6 have definitive (autopsy-proven) early-onset AD, 93 have probable early-onset AD, and 29 have possible early-onset AD. SETTING: Community based in Antioquia, Colombia. PATIENTS: A population-based sample in which all members of 5 extended families (nearly 3000 individuals) were surveyed. Criteria for inclusion required obtaining sufficient information to categorize the individual as affected. MAIN OUTCOME MEASURES: Age at onset, neuropsychological profile, neurologic history, and examination. RESULTS: The patients had a mean age at onset of 46.8 years (range, 34-62 years). The average interval until death was 8 years. Headache was noted in affected individuals significantly more frequently than in those not affected. The most frequent presentation was memory loss followed by behavior and personality changes and progressive loss of language ability. In the final stages, gait disturbances, seizures, and myoclonus were frequent. CONCLUSIONS: Other than the early onset, this clinical phenotype is indistinguishable from sporadic AD except that affected individuals frequently complained of headache preceding and during the disease. Despite the uniform genetic basis for the disease, there was significant variability in the age at onset, suggesting an important role for environmental factors or genetic modifiers in determining the age at onset.

Integrity signals

Registry

Crossref · 10.1001/jama.1997.03540340027028

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Boston Naming Test
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
Untitled work
(1998) · Cited by 4,172
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
Reitan, R. M., & Wolfson, D. E. (1993) · Medical Entomology and Zoology · Cited by 3,413

Show all 52 references

Sorted by citations

Items 101–200 of 353

Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations
Lee, G. J., Lu, P. H., Medina, L. D., Rodríguez‐Agudelo, Y., Melchor, S. J., Coppola, G., Braskie, M. N., Hua, X., Apostolova, L. G., Leow, A., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-302087 · Cited by 54
Efficacy and safety studies of gantenerumab in patients with Alzheimer’s disease
Panza, F., Solfrizzi, V., Imbimbo, B. P., Giannini, M., Santamato, A., Seripa, D., & Logroscino, G. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.945522 · Cited by 51
Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer’s disease
Habib, M., Mak, E., Gabel, S., Su, L., Williams, G., Waldman, A., Wells, K., Ritchie, K., Ritchie, C., & O’Brien, J. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.03.004 · Cited by 53
Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery
Hampel, H. J., Vergallo, A., Caraci, F., Cuello, A. C., Lemercier, P., Vellas, B. J., Giudici, K. V., Baldacci, F., Hänisch, B., Haberkamp, M., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108081 · Cited by 52
Event-related potential markers of brain changes in preclinical familial Alzheimer disease
Quiroz, Y. T., Ally, B. A., Celone, K., McKeever, J. D., Ruiz‐Rizzo, A. L., Lopera, F. J., Stern, C. E., & Budson, A. E. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b1b0 · Cited by 50
Self-citation
Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges
Cynis, H., Frost, J. L., Crehan, H., & Lemere, C. A. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0115-2 · Cited by 49
A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures
Ezquerra, M., Pardo, C. C., Blesa, R., Gelpí, J. L., Ballesta, F., & Oliva, R. (1999) · Neurology · doi:10.1212/wnl.52.3.566 · Cited by 48
A Novel Mutation in the PSEN2 Gene (T430M) Associated With Variable Expression in a Family With Early-Onset Alzheimer Disease
Ezquerra, M., Lleó, A., Castellvı́, M., Queralt, R., Santacruz, P., Pástor, P., Molinuevo, J. L., Blesa, R., & Oliva, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1149 · Cited by 48
Wide Range of Disease Onset in a Family With Alzheimer Disease and a His163Tyr Mutation in the Presenilin-1 Gene
Axelman, K., Basun, H., & Lannfelt, L. (1998) · Archives of Neurology · doi:10.1001/archneur.55.5.698 · Cited by 47
Genes and susceptible loci of Alzheimer’s disease
Shastry, B. S., & Giblin, F. J. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00156-7 · Cited by 48
Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's disease
Vélez, J. I., Chandrasekharappa, S. C., Henao, E., Martinez, A. F., Harper, U., Jones, M., Solomon, B. D., Lopez, L., Garcia, G., Aguirre-Acevedo, D. C., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.81 · Cited by 44
Self-citation
The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives
Casallas, J. C. G., & Bustos, R. (2018) · Brain Sciences · doi:10.3390/brainsci8120222 · Cited by 49
Clinical Assessment and Diagnosis in Social Work Practice
Corcoran, J., & Walsh, J. A. (2006) · Cited by 43
Overcoming barriers in cognitive assessment of Alzheimer's disease
Parra, M. A. (2014) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642014dn82000002 · Cited by 42
The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset
Panza, F., Seripa, D., Lozupone, M., Solfrizzi, V., Imbimbo, B. P., Barulli, M. R., Tortelli, R., Capozzo, R., Bisceglia, P., Dimitri, A., et al. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1389885 · Cited by 41
Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting
Zhang, Y., Xie, J., Xu, X., Hu, J., Xu, T., Jin, S., Yang, S., & Wang, J. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-00336-7 · Cited by 44
A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects
Acosta‐Uribe, J., Aguillon, D. F., Cochran, J. N., Giraldo, M., Madrigal, L., Killingsworth, B. W., Singhal, R., Labib, S., Alzate, D., Velilla, L. M., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01035-9 · Cited by 43
Self-citation
Cognitive changes in the preclinical phase of familial Alzheimer's disease
Arango‐Lasprilla, J. C., Cuetos, F., Valencia, C., Uribe, C., & Lopera, F. J. (2007) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390601174151 · Cited by 41
Self-citation
ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280APS‐1mutation
Bobes, M. A., García, Y. F., Lopera, F. J., Quiroz, Y. T., Galán, L., Vega, M., Trujillo‐Barreto, N. J., Valdés-Sosa, M. J., & Valdes-Sosa, P. A. (2009) · Human Brain Mapping · doi:10.1002/hbm.20861 · Cited by 42
Self-citation
GWAS reveals new recessive loci associated with non-syndromic facial clefting
Camargo, M., Rivera, D., Moreno, L. M., Lidral, A. C., Harper, U. L., Jones, M. S., Solomon, B. D., Roessler, E., Velez, J. I., Martinez, A. F., et al. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.06.005 · Cited by 40
Monogenetic determinants of Alzheimer's disease: APP mutations
Goate, A. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050218 · Cited by 41
Aluminum and Tau in Neurofibrillary Tangles in Familial Alzheimer’s Disease
Mold, M. J., O’Farrell, A., Morris, B., & Exley, C. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210011 · Cited by 42
Inhibition of ferroptosis through regulating neuronal calcium homeostasis: An emerging therapeutic target for Alzheimer’s disease
Sun, Y., Yan, C., He, L., Xiang, S., Wang, P., Li, Z., Chen, Y., Zhao, J., Yuan, Y., Wang, W., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101899 · Cited by 40
Autosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical AD
Schindler, S. E., & Fagan, A. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00142 · Cited by 40
Ultrastructure evidence of necrotic neural cell death in familial Alzheimer's disease brains bearing presenilin-1 E280A mutation1
Velez‐Pardo, C., Tobón‐Arroyave, S. I., Lopera, F. J., Castaño, A. D., & Jiménez-Del-Río, M. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3408 · Cited by 38
Self-citation
Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin
Ringman, J. M. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2002.005025 · Cited by 37
What the Study of Persons At Risk for Familial Alzheimer's Disease Can Tell Us About the Earliest Stages of the Disorder: A Review
Ringman, J. M. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281878 · Cited by 37
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation
Singleton, A. B. (2000) · Brain · doi:10.1093/brain/123.12.2467 · Cited by 36
Brain Information Sharing During Visual Short-Term Memory Binding Yields a Memory Biomarker for Familial Alzheimer's Disease
Parra, M. A., Mikulan, E., Trujillo, N., Sala, S. D., Lopera, F. J., Manes, F. F., Starr, J. M., & Ibáñez, A. M. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170614163316 · Cited by 39
Self-citation
Early‐onset Alzheimer's disease with presenilin‐1 M139V mutation: clinical, neuropsychological and neuropathological study
Larner, A. J., & du Plessis, D. G. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00597.x · Cited by 36
Developing a Spatial Navigation Screening Tool Sensitive to the Preclinical Alzheimer Disease Continuum
Allison, S. L., Rodebaugh, T. L., Johnston, C., Fagan, A. M., Morris, J. C., & Head, D. M. (2019) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acz019 · Cited by 35
Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives
Usman, M. B., Bhardwaj, S., Roychoudhury, S., Kumar, D., Alexiou, A. T., Kumar, P., Ambasta, R. K., Prasher, P., Shukla, S. D., Upadhye, V. J., et al. (2021) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2021.52 · Cited by 37
Single-Gene Determinants of Epilepsy ComorbidityPreprint
Noebels, J. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022756 · Cited by 35
Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation
Ringman, J. M., Gylys, K. H., Medina, L. D., Fox, M., Kepe, V., Flores, D. L., Apostolova, L. G., Barrio, J. R., Small, G., Silverman, D. H. S., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.039 · Cited by 35
Attention‐deficit/hyperactivity disorder (ADHD): feasibility of linkage analysis in a genetic isolate using extended and multigenerational pedigrees
Arcos‐Burgos, M., Castellanos, F. X., Lopera, F. J., Pineda, D. A., Palacio, J. D., García-Barrera, M. A., Henao, G., Palacio, L., Berg, K., Bailey‐Wilson, J. E., et al. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.610503.x · Cited by 33
Self-citation
Genetic origin of a large family with a novel PSEN1 mutation (Ile416Thr)
Aguilar, L. R., Acosta‐Uribe, J., Giraldo, M., Moreno, S., Baena, A. Y., Alzate, D., Cuastumal, A. R., Aguillon, D. F., Madrigal, L., Saldarriaga, A., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.12.010 · Cited by 31
Self-citation
Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer’s disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications
Soto‐Mercado, V., Mendivil‐Perez, M., Velez‐Pardo, C., Lopera, F. J., & Jiménez-Del-Río, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0221669 · Cited by 33
Self-citation
Neuropsychological function in nondemented carriers of presenilin-1 mutations
Ringman, J. M., Dı́az-Olavarrieta, C., Rodriguez, Y., Chavez, M., Fairbanks, L. A., Paz-Rodríguez, F., Varpetian, A., Maldonado, H. C., Macías-Islas, M. Á., Murrell, J. R., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000172919.50001.d6 · Cited by 32
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial
Ríos‐Romenets, S., Lopera, F. J., Sink, K. M., Hu, N., Lian, Q., Guthrie, H., Smith, J. P., Cho, W., Mackey, H. M., Langbaum, J. B. S., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12109 · Cited by 31
Self-citation
Cognitive Decline in Patients with Familial Alzheimer's Disease Associated with E280a Presenilin-1 Mutation: A Longitudinal Study
Rosselli, M., Ardila, A., Moreno, S., Standish, V., Arango‐Lasprilla, J. C., Tirado, V., Ossa, J. E., Goate, A., Kosik, K. S., & Lopera, F. (2000) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/1380-3395(200008)22:4;1-0;ft483 · Cited by 31
Self-citation
Subjective memory complaints in preclinical autosomal dominant Alzheimer disease
Norton, D. J., Amariglio, R. E., Protas, H. D., Chen, K., Aguirre–Acevedo, D. C., Pulsifer, B., Castrillón, G., Tirado, V., Muñoz, C., Tariot, P. N., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004533 · Cited by 32
Self-citation
Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease
Hanseeuw, B. J., Lopera, F. J., Sperling, R. A., Norton, D. J., Guzmán‐Vélez, E., Baena, A. Y., Pardilla‐Delgado, E., Schultz, A. P., Gatchel, J. R., Jin, D. S., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0468-1 · Cited by 32
Self-citation
An 1H‐MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers
Londoño, A. C., Castellanos, F. X., Arbeláez, A., Ruiz‐Rizzo, A. L., Aguirre–Acevedo, D. C., Richardson, A., Easteal, S., Lidbury, B. A., Arcos‐Burgos, M., & Lopera, F. J. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.08.282 · Cited by 30
Self-citation
Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer’s Disease and Related Neurological Disorders
Mold, M. J., O’Farrell, A., Morris, B., & Exley, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200838 · Cited by 31
Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes
Llibre‐Guerra, J. J., Li, Y., Allegri, R., Méndez, P. C., Surace, E. I., Rodríguez, J. J. L., Sosa, A. L., Aláez‐Verson, C., Longoria-Ibarrola, E. M., Téllez‐Martínez, J. A., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12227 · Cited by 29
Self-citation
Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection
Almeida, M. C., Eger, S. J., He, C., Audouard, M., Nikitina, A. A., Glasauer, S. M. K., Han, D., Mejía‐Cupajita, B., Acosta‐Uribe, J., Villalba‐Moreno, N. D., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.02.009 · Cited by 34
Self-citation
Pathogenic Aβ generation in familial Alzheimer’s disease: novel mechanistic insights and therapeutic implications
Trambauer, J., Fukumori, A., & Steiner, H. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.011 · Cited by 28
PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
Ghisays, V., Lopera, F. J., Goradia, D. D., Protas, H. D., Malek‐Ahmadi, M. H., Chen, Y., Devadas, V., Luo, J., Lee, W., Baena, A. Y., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102749 · Cited by 30
Self-citation
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Reiss, A. B., Muhieddine, D., Jacob, B., Mesbah, M., Pinkhasov, A., Gomolin, I. H., Stecker, M. M., Wısnıewskı, T., & Leon, J. D. (2023) · Medicina · doi:10.3390/medicina59061084 · Cited by 31
Epilepsy and neurodegenerative diseases in adults: a clinical review
Vercueil, L. (2006) · Epileptic Disorders · doi:10.1684/j.1950-6945.2006.tb00199.x · Cited by 30
Dual Task Abilities as a Possible Preclinical Marker of Alzheimer's Disease in Carriers of the E280A Presenilin-1 Mutation
MacPherson, S. E., Parra, M. A., Moreno, S., Lopera, F. J., & Sala, S. D. (2011) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617711001561 · Cited by 27
Self-citation
Insulin-like growth factor-1 prevents Aβ[25–35]/(H2O2)- induced apoptosis in lymphocytes by reciprocal NF-κB activation and p53 inhibition via PI3K-dependent pathway
Jiménez-Del-Río, M., & Velez‐Pardo, C. (2006) · Growth Factors · doi:10.1080/08977190500361788 · Cited by 27
Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City
Sosa, A. L., Brucki, S. M. D., Crivelli, L., Lopera, F. J., Acosta, D. M., Acosta‐Uribe, J., Aguilar, D., Aguilar-Navarro, S. G., Allegri, R., Bertolucci, P. H. F., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13850 · Cited by 30
Self-citation
Cerebellar Amyloid-β Plaques: Disturbed Cortical Circuitry in AβPP/PS1 Transgenic Mice as a Model of Familial Alzheimer's Disease
Lomoio, S., López‐González, I., Aso, E., Carmona, M., Torrejón-Escribano, B., Scherini, E., & Ferrer, I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112198 · Cited by 27
New Genes and New Insights from Old Genes
Ringman, J. M., & Coppola, G. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000429179.21977.a1 · Cited by 27
Macromolecular complex in recognition and proteolysis of amyloid precursor protein in Alzheimer’s disease
Zhou, R., Yang, G., & Shi, Y. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.09.004 · Cited by 26
Cortical and subcortical diseases: Do true neuropsychological differences exist?☆
Arango‐Lasprilla, J. C., Rogers, H. L., Lengenfelder, J., DeLuca, J., MORENO, S., & LOPERA, F. (2005) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2005.07.004 · Cited by 26
Self-citation
AAVrh.10 delivery of novel APOE2-Christchurch variant suppresses amyloid and Tau pathology in alzheimer's disease mice
Günaydin, C., Sondhi, D., Kaminsky, S. M., Lephart, H. C., Leopold, P. L., Hackett, N. R., Khanna, R., & Crystal, R. G. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.11.003 · Cited by 26
Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene
Aguirre-Acevedo, D. C., Jaimes-Barragán, F., Henao, E., Tirado, V., Muñoz, C., Reiman, E. M., Tariot, P. N., Langbaum, J. B., & Lopera, F. (2016) · International Psychogeriatrics · doi:10.1017/s1041610215001660 · Cited by 25
Self-citation
A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer’s Disease
Vélez, J. I., Rivera, D., Mastronardi, C. A., Patel, H. R., Tobón, C., Villegas, A., Cai, Y., Easteal, S., Lopera, F., & Arcos-Burgos, M. (2016) · Neural Plasticity · doi:10.1155/2016/9760314 · Cited by 25
Self-citation
Spectral Analysis of EEG in Familial Alzheimer’s Disease with E280A Presenilin-1 Mutation Gene
Rodriguez, R., Lopera, F. J., Alvarez, A., García, Y. F., Galán, L., Quiroz, Y. T., & Bobes, M. A. (2014) · International Journal of Alzheimer s Disease · doi:10.1155/2014/180741 · Cited by 24
Self-citation
How understudied populations have contributed to our understanding of Alzheimer’s disease genetics
Dehghani, N., Brás, J., & Guerreiro, R. J. (2021) · Brain · doi:10.1093/brain/awab028 · Cited by 25
AIBP controls TLR4 inflammarafts and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
Kim, Y. S., Choi, S., Kim, K.-Y., Pelaez, J. M. N., Perkins, G. A., Choi, S., Kim, J., Nazarenkov, N., Rissman, R. A., Ju, W., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03214-4 · Cited by 24
Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer’s Disease
Ye, M., Chung, H., An, Y. H., Lim, S.-J., Choi, W., Yu, A., Kim, J. S., Kang, M., Cho, S., Shim, I., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9458-x · Cited by 22
A novel mutation (L250V) in the presenilin 1 gene in a Japanese familial Alzheimer's disease with myoclonus and generalized convulsion
Furuya, H., Yasuda, M., Terasawa, K.-J., Tanaka, K., Murai, H., Kira, J., & Ohyagi, Y. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00466-5 · Cited by 24
Multiple sclerosis in the tropics: genetic association to STR’s loci spanning the HLA and TNF
Palacio, L. G., Rivera, D., Builes, J. J., Jiménez, M. E., Salgar, M., Anaya, J., Jiménez, I., Camargo, M., Arcos‐Burgos, M., & Sánchez, J. L. (2002) · Multiple Sclerosis Journal · doi:10.1191/1352458502ms804oa · Cited by 23
Exploratory data from complete genomes of familial alzheimer disease age-at-onset outliers
Lalli, M. A., Garcia, G., Madrigal, L., Arcos-Burgos, M., Arcila, M. L., Kosik, K. S., & Lopera, F. (2012) · Human Mutation · doi:10.1002/humu.22167 · Cited by 19
Self-citation
Increased Prevalence of Significant Recurrent Headache in Preclinical Familial Alzheimer’s Disease Mutation Carriers
Ringman, J. M., Romano, J. D., Medina, L. D., Rodríguez‐Agudelo, Y., Schaffer, B., Varpetian, A., Ortiz, F., Fitten, L. J., Cummings, J. L., & Baloh, R. W. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000121986 · Cited by 22
Network medicine in drug design: implications for neuroinflammation
Ghosh, S., & Basu, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.018 · Cited by 22
A computer-simulated mechanism of familial Alzheimer’s disease: Mutations enhance thermal dynamics and favor looser substrate-binding to γ-secretase
Dehury, B., Somavarapu, A. K., & Kepp, K. P. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107648 · Cited by 22
Phenotypic Similarities Between Late-Onset Autosomal Dominant and Sporadic Alzheimer Disease
Day, G. S., Musiek, E. S., Roe, C. M., Norton, J. B., Goate, A., Cruchaga, C., Cairns, N. J., & Morris, J. C. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.1236 · Cited by 21
Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred
Cochran, J. N., Acosta‐Uribe, J., Esposito, B. T., Madrigal, L., Aguillón, D., Giraldo, M. M., Taylor, J. W., Bradley, J., Fulton‐Howard, B., Andrews, S. J., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13021 · Cited by 21
Self-citation
“My backpack is so heavy”: Experiences of Latino caregivers of family with early‐onset Alzheimer's
Withers, M. H., Cortez‐Sanchez, K., Herrera, J., Ringman, J. M., & Segal‐Gidan, F. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17091 · Cited by 21
Short-term memory conjunctive binding in Alzheimer’s disease: A systematic review and meta-analysis.
Cecchini, M. A., Parra, M. A., Brazzelli, M. G., Logie, R. H., & Sala, S. D. (2022) · Neuropsychology · doi:10.1037/neu0000825 · Cited by 21
Familial Presenilin Mutations and Sporadic Alzheimer’s Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
Roher, A. E., Maarouf, C. L., & Kokjohn, T. A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150757 · Cited by 22
Las fronteras entre el envejecimiento cognitivo normal y la enfermedad de Alzheimer.: El concepto de deterioro cognitivo leve
Otero, J. L., & Scheitler, L. F. (2003) · Revista Médica del Uruguay · Cited by 20
Neuropsychological stydy of familial Alzheimer's disease caused by mutation E280A in the presenilin 1 gene
Arango‐Lasprilla, J. C., Iglesias, J., & Lopera, F. J. (2003) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750301800306 · Cited by 21
Self-citation
Alzheimer Disease Research Comes of Age The Pace Accelerates
Morrison‐Bogorad, M. (1997) · JAMA · doi:10.1001/jama.1997.03540340071036 · Cited by 21
Alzheimer’s Disease, Drosophila melanogaster and Polyphenols
Jiménez-Del-Río, M., & Velez‐Pardo, C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_2 · Cited by 21
“In the flesh”: Narratives of family caregivers at risk of Early-onset Familial Alzheimer’s Disease
García-Toro, M., Gómez, M. C. S., Madrigal, L., & Lopera, F. J. (2018) · Dementia · doi:10.1177/1471301218801501 · Cited by 24
Self-citation
Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
Wang, G., Xiong, C., McDade, E., Hassenstab, J. J., Aschenbrenner, A. J., Fagan, A. M., Benzinger, T. L. S., Gordon, B. A., Morris, J. C., Li, Y., et al. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.10.009 · Cited by 19
Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139
Hüll, M., Fiebich, B. L., Dykierek, P., Schmidtke, K., Nitzsche, E. U., Orszagh, M., Deuschl, G., Moser, E. A., Schumacher, M. C., Lücking, C. H., et al. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050028 · Cited by 20
Gene replacement‐Alzheimer's disease (GR‐AD): Modeling the genetics of human dementias in mice
Benzow, K. A., Karanjeet, K., Oblak, A. L., Carter, G. W., Sasner, M., & Koob, M. D. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13730 · Cited by 15
Alzheimer's disease: Genetic evidence points to a single pathogenesis
Hardy, J. (2003) · Annals of Neurology · doi:10.1002/ana.10624 · Cited by 19
Homozygosity of the autosomal dominant Alzheimer disease presenilin 1 E280A mutation
Kosik, K. S., Muñoz, C., López, L., Arcila, M. L., García, G., Madrigal, L., Moreno, S., Romenets, S. R., Lopez, H., Gutierrez, M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001130 · Cited by 19
Self-citation
The Colombian Alzheimer's Prevention Initiative (API) Registry
Ríos‐Romenets, S., Lopez, H., López, L., Hincapié, L., Saldarriaga, A., Madrigal, L., Piedrahita, F., Navarro, A., Acosta‐Uribe, J., Ramírez, L., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.09.010 · Cited by 19
Self-citation
Familial Alzheimer’s Disease
Velez‐Pardo, C., Jiménez-Del-Río, M., & Lopera, F. J. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00189-x · Cited by 19
Self-citation
(−)-Epigallocatechin-3-Gallate Diminishes Intra-and Extracellular Amyloid-Induced Cytotoxic Effects on Cholinergic-like Neurons from Familial Alzheimer’s Disease PSEN1 E280A
Soto‐Mercado, V., Mendivil‐Perez, M., Velez‐Pardo, C., & Jiménez-Del-Río, M. (2021) · Biomolecules · doi:10.3390/biom11121845 · Cited by 18
Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer’s Disease
Penny, W. D., Iglesias-Fuster, J., Quiroz, Y. T., Lopera, F. J., & Bobes, M. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170405 · Cited by 18
Self-citation
Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms
Armstrong, G. W., Kim, L. A., Vingopoulos, F., Park, J. Y., Garg, I., Kasetty, M. A., Silverman, R. F., Zeng, R., Douglas, V. P., Lopera, F. J., et al. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.4909 · Cited by 17
Self-citation
Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer’s Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor
Soto‐Mercado, V., Mendivil‐Perez, M., Jiménez-Del-Río, M., & Velez‐Pardo, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201045 · Cited by 19
Strong Evidence for a Genetic Contribution to Late-Onset Alzheimer’s Disease Mortality: A Population-Based Study
Kauwe, J. S. K., Ridge, P. G., Foster, N. L., & Cannon‐Albright, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077087 · Cited by 18
Clinical, Genetic, and Neuroimaging Features of Early Onset Alzheimer Disease: The Challenges of Diagnosis and Treatment
Alberici, A., Benussi, A., Premi, E., Borroni, B., & Padovani, A. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141107151606 · Cited by 16
The Role of Gait Speed in Dementia: A Secondary Analysis from the SABE Colombia Study
Garcia-Cifuentes, E. R., Márquez, I., Vásquez, D., Aguillon, D. F., Borda, M. G., Lopera, F. J., & Cano, C. A. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000510494 · Cited by 16
Self-citation
Molecular Genetics of Familial Alzheimer Disease
Shastry, B. S. (1998) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40324-6 · Cited by 16
Disorders of higher gaze control
Kennard, C. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52903-9.00020-0 · Cited by 17
Association analysis of PTPN22 , CTLA4 and IFIH1 genes with type 1 diabetes in C olombian families在哥伦比亚家族中进行的PTPN22、CTLA4以及IFIH1基因与1型糖尿病的相关性分析
Rodríguez, A. M., Alfaro, J. M. E., Balthazar, V., & Pineda-Trujillo, N. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12192 · Cited by 16
Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: A systematic review
Zhang, S., Lei, C., Liu, P., Zhang, M., Tao, W., Liu, H., & Liu, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.003 · Cited by 16
Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer’s Disease Detected Using Quantitative Electroencephalography
Ochoa, J. F., Alonso, J. F., Duque, J. E., Tobón, C., Baena, A. Y., Lopera, F. J., Mañanas, M. Á., & Hernández, A. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161291 · Cited by 15
Self-citation
Novel MLH1 duplication identified in Colombian families with Lynch syndrome
Alonso‐Espinaco, V., Giraldez, M. D., Trujillo, C., van der Klift, H. M., Muñoz, J., Balaguer, F., Ocaña, T., Madrigal, I., Jones, A. M., Echeverry, M. M., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e318202e10b · Cited by 15

Authors: Lopera, F.
Affiliations: Universidad de Antioquia (CO)
Corresponding author: Lopera, Francisco
ORCID: Lopera, Francisco
Venue: JAMA: The Journal of the American Medical Association
Publisher: American Medical Association (AMA)
Published: 1997-03-12
Volume: 277
Issue: 10
Pages: 793
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1997.03540340027028
OpenAlex: W2110985141
Cited by: 351
References: 52
Citations by year: 2026: 5 · 2025: 13 · 2024: 19 · 2023: 17 · 2022: 8 · 2021: 14 · 2020: 16 · 2019: 16 · 2018: 13 · 2017: 13 · 2016: 19 · 2015: 22 · 2014: 21 · 2013: 14 · 2012: 23
FWCI: 6.03
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: early-onset Alzheimer's disease, presenilin 1, PSEN1 E280A mutation, familial Alzheimer's disease, clinical phenotype, age of onset, headache, memory loss, behavioral and personality changes, language loss, gait disturbance, seizures, myoclonus, genetic modifiers, extended family
MeSH terms: Adult, Alanine, Alzheimer Disease, Autopsy, Brain, Codon, Female, Headache, Humans, Male, Membrane Proteins, Middle Aged, Neuropsychological Tests, Pedigree, Phenotype, Point Mutation, Age of Onset, Glutamic Acid, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical Features of Early-Onset Alzheimer Disease in a Large Kindred With an E280A Presenilin-1 Mutation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks